In this trial of preoperative sickle cell patients, they were randomized to preoperative RBC transfusions or none; those in the non-transfusion group had higher complication rates (39% vs 15%) and serious adverse events (10% vs 1%) compared to those in the transfusion group (the most common was acute chest). Sickle cell patients so appear to benefit from preoperative RBC transfusions (abstract).
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.